Clinical Trials Logo

Clinical Trial Summary

The study is a prospective multicenter registry. Consecutive patients with indications of implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be enrolled. The primary objective of the study is to determine the predictors of appropriate anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with an ICD. Secondary objectives of the study are: - the incidence of anti-tachycardia therapies; - the predictors of inappropriate therapy and onset of arrhythmia burden; - the adherence to the current guidelines in the Italian clinical practice; - the predictors of heart failure (HF) onset and response to cardiac resynchronization therapy (CRT).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02275637
Study type Observational
Source IRCCS Policlinico S. Matteo
Contact Maurizio Eugenio Landolina, MD
Phone 0382.501276
Email clinical-estimate@isis.it
Status Recruiting
Phase
Start date September 2014
Completion date December 2023